SpringWorks Therapeutics, Inc. (SWTX) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 7 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for SWTX is $62.50, representing a +33.0% upside from the current price of $46.99. Price targets range from a low of $47.00 to a high of $78.00.
